Mevacor Daily: FDA Panels Probe Long-Term Compliance With Statin Regimen
This article was originally published in The Pink Sheet Daily
Executive Summary
NDAC, Endocrinologic drug committees focus debate on label comprehension, liver toxicity and pregnant women. Committee members question consumer self-diagnosing capability, compliance discipline for the OTC 20 mg lovastatin dose.